Pivotal study of Diazoxide Choline Controlled-Release Tablet (DCCR) for the treatment of Prader-Willi Syndrome
Phase of Trial: Phase II/III
Latest Information Update: 11 May 2017
At a glance
- Drugs Diazoxide
- Indications Prader-Willi syndrome
- Focus Registrational; Therapeutic Use
- Sponsors Essentialis
- 15 Mar 2017 According to Capnia media release, company is planning to initiate this trial later this year.
- 27 Dec 2016 According to Capnia media release, enrollment is expected to begin in second half of 2017.
- 01 Apr 2015 New trial record